Elevated serum levels of retinol-binding protein 4 (RBP4), a retinol transporter secreted by adipocytes and liver, are associated with insulin resistance and diabetes. Graham et al., therefore ...

“These are devastating diseases with limited treatment options,” said Curt Breneman, Ph.D., dean of Rensselaer’s School of ...

Rensselaer Polytechnic Institute's Christopher Cioffi, Ph.D., Thomas and Constance D'Ambra Professor in Organic Chemistry, has been collaborating with Konstantin Petrukhin, Ph.D., Professor of ...

Rensselaer researchers receive $6.4 million grant from NEI to seek new treatment for blindness-causing diseases.

For instance, one substance is the retinol-binding protein RBP4, that was discovered in a 16-year study of nurses, published in an American journal for the National Library of Medicine, in 2013. This ...

Tinlarebant works by reducing and maintaining levels of serum retinol binding protein 4 (RBP4), the sole carrier protein for retinol transport from the liver to the eye. By modulating the amount ...

Hill A.A., Kim M., Zegarra-Ruiz D.F., Chang L.C., Norwood K., Assié A., Wu W.H., Renfroe M.C., Song H.W., Major A.M., Samuel B.S., Hyser J.M., Longman R.S., Diehl G ...

We also research some of these topics in more of an applied context. Basic work on biological transport and transport proteins is also considered in a pathological or therapeutic perspective: basic ...

Bisretinoids are by-products of the visual cycle, which is dependent on the supply of vitamin A (retinol) to the eye. Tinlarebant works by reducing and maintaining levels of serum retinol binding ...